Aberrant and/or excessive NLRP3 inflammasome activation has been implicated in several conditions, including diabetes, cryopyrin-associated periodic syndromes, neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease, as well as both ischemic and hemorrhagic stroke.17 Here, NLRP3 is linked to neurodegenerative disease.